| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 138.169 | 123.034 | 83.403 | 66.105 | 80.095 | 113.971 | 110.026 | 103.182 | 108.829 | 134.599 |
| Total Income - EUR | 138.344 | 123.045 | 83.450 | 88.923 | 80.197 | 114.531 | 110.026 | 103.182 | 108.829 | 134.654 |
| Total Expenses - EUR | 152.578 | 128.202 | 73.797 | 89.717 | 110.029 | 117.628 | 123.126 | 106.981 | 93.143 | 100.811 |
| Gross Profit/Loss - EUR | -14.234 | -5.157 | 9.653 | -794 | -29.832 | -3.096 | -13.100 | -3.799 | 15.686 | 33.843 |
| Net Profit/Loss - EUR | -14.234 | -5.157 | 8.892 | -1.683 | -30.631 | -4.161 | -14.201 | -4.831 | 14.598 | 30.495 |
| Employees | 2 | 2 | 2 | 3 | 3 | 3 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Pharma Vic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 64.605 | 50.426 | 50.074 | 136.724 | 108.602 | 81.698 | 57.017 | 49.378 | 47.973 | 48.039 |
| Current Assets | 40.256 | 22.773 | 25.045 | 28.260 | 25.021 | 19.766 | 20.350 | 17.180 | 21.607 | 22.744 |
| Inventories | 26.101 | 9.046 | 19.396 | 19.688 | 18.334 | 15.403 | 14.983 | 14.129 | 13.477 | 18.989 |
| Receivables | 10.249 | 4.979 | 3.945 | 5.550 | 3.717 | 919 | 969 | 861 | 766 | 540 |
| Cash | 3.906 | 8.748 | 1.703 | 3.021 | 2.970 | 3.444 | 4.398 | 2.190 | 7.365 | 3.216 |
| Shareholders Funds | -9.348 | -14.409 | -5.273 | -6.860 | -37.358 | -40.810 | -54.106 | -59.105 | -44.328 | -13.586 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 114.209 | 87.608 | 80.392 | 171.844 | 170.986 | 142.742 | 131.871 | 126.021 | 113.971 | 84.447 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Pharma Vic S.r.l.